Covalon Technologies (CVALF) Projected to Post Quarterly Earnings on Tuesday

Covalon Technologies (OTCMKTS:CVALF) is expected to be announcing its earnings results before the market opens on Tuesday, May 27th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $7.67 million for the quarter.

Covalon Technologies (OTCMKTS:CVALF) last posted its earnings results on Friday, February 21st. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.06. The company had revenue of $5.84 million for the quarter, compared to analyst estimates of $6.37 million. Covalon Technologies had a net margin of 8.58% and a return on equity of 12.33%.

Covalon Technologies Stock Performance

OTCMKTS:CVALF opened at $1.86 on Tuesday. The firm has a market cap of $51.00 million, a price-to-earnings ratio of 26.58 and a beta of 0.49. Covalon Technologies has a 52 week low of $0.77 and a 52 week high of $3.08. The firm has a 50-day moving average price of $1.69 and a two-hundred day moving average price of $2.08.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.